Use of Glucose Monitoring Devices Among Adults with Diabetes in Germany: Results from Nationwide Surveys Conducted in 2017 and 2021/2022
- 2 June 2025
- journal article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 27 (6) , 488-499
Abstract
Background: Devices for continuous glucose monitoring (CGM) have been developed to optimize blood glucose control and liberate people with diabetes from finger-prick glucose measurements. Since 2016, the devices have been reimbursed in Germany for people with diabetes receiving insulin therapy, resulting in their increased use among people with type 1 diabetes (T1D) and type 2 diabetes (T2D). We investigated the prevalence of CGM use and its associated factors among German adults with diabetes in 2017 and 2021/2022. Methods: Participants aged 18 years or older with diagnosed diabetes were identified from two nationwide population-based telephone surveys in 2017 ( n = 1396) and 2021/2022 ( n = 1456). Prevalence and dynamics of CGM use were examined overall and stratified by sociodemographic and diabetes-related characteristics. Factors associated with CGM use were obtained from logistic regression models. Results: The overall prevalence of CGM use was 8.2% in 2017 and 16.6% in 2021/2022. An increase in CGM use was observed across all the subgroups except for those without antidiabetic medications. CGM use increased from 31.1% to 75.4% in adults with T1D, from 6.3% to 13.6% in adults with T2D, and from 14.6% to 36.7% in all insulin users. In both surveys, younger age, insulin use, T1D, and reporting hypoglycemia were associated with CGM use. In addition, in 2017, higher education level and absence of obesity were associated with CGM use, whereas in 2021/2022, participation in the diabetes self-management education program and higher self-assessed quality of diabetes care were associated with CGM use. Conclusion: Among adults with diabetes in Germany, CGM use increased about twofold within 5 years, irrespective of sociodemographic factors. Educational inequality in CGM use diminished over time. The higher self-rated quality of diabetes care associated with the recent use of CGM provides further evidence to support its use among all adults with diabetes in Germany.Keywords
This publication has 51 references indexed in Scilit:
- Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysisDiabetologia, 2024
- Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 DiseaseDiabetes Therapy, 2023
- Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology SettingsJournal of General Internal Medicine, 2023
- Diabetes-related distress and associated factors among adults with diabetes in Germany: Results of the nationwide study “Disease knowledge and information needs – Diabetes mellitus 2017”Journal of Psychosomatic Research, 2022
- American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 UpdateEndocrine Practice, 2022
- Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes MellitusDiabetes Therapy, 2022
- Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysisDiabetologia, 2022
- Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesJAMA, 2021
- Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trialsActa Diabetologica, 2020
- Prävalenz und zeitliche Entwicklung des bekannten Diabetes mellitusBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2013